-
Tus-Pharma to Acquire Sinotau Pharma for RMB 220 Million
•
China-based Tus-Pharmaceutical Group Co., Ltd (SHE: 000590) has announced plans to acquire 100% of Guangdong Sinotau Pharmaceutical Co., Ltd for RMB 220 million (USD 32.6 million) in cash. The deal aims to expand Tus-Pharma’s manufacturing footprint and product portfolio. Transaction DetailsSinotau Pharma owns a 14,496 sq.m factory with three production…
